AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35453106 — intervention group
Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 293
Study 34067292 — intervention group
Group type: EXPERIMENTAL
Intervention: PA coaching intervention designed to increase objectively measured moderate‐to‐vigorous‐intensity PA (MVPA)
Number of subjects: 120
Study 34067292 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 33411687 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin
Number of subjects: 365
Study 33411687 — intervention group
Group type: COMPARATOR
Intervention: clopidogrel/aspirin
Number of subjects: 365
Study 34605897 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat treatment
Number of subjects: 1070
Study 34869490 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for tinnitus
Number of subjects: 158
Study 34869490 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 158
Study 34730821 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing Stigma Among Healthcare Providers (RESHAPE) group
Number of subjects: 88
Study 34730821 — intervention group
Group type: COMPARATOR
Intervention: Control group (mhGAP-IG training)
Number of subjects: 88
Study 33043881 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care (advice and up to two sessions of physiotherapy)
Number of subjects: 476
Study 33043881 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care (up to six sessions of physiotherapy)
Number of subjects: 476
Study 33043881 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified care (fast-tracked to MRI and spinal specialist opinion)
Number of subjects: 476
Study 33043881 — intervention group
Group type: COMPARATOR
Intervention: Usual care (stepped-care approach without stratification)
Number of subjects: 476
Study 35363598 — intervention group
Group type: EXPERIMENTAL
Intervention: BWHIIT (n = 20)
Number of subjects: 30
Study 35363598 — intervention group
Group type: COMPARATOR
Intervention: CON (n = 10)
Number of subjects: 30
Study 35363598 — intervention group
Group type: EXPERIMENTAL
Intervention: BWHIIT
Number of subjects: 30
Study 35363598 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 30
Study 34030999 — intervention group
Group type: EXPERIMENTAL
Intervention: Opaque eye coverage during surgery
Number of subjects: 60
Study 34030999 — intervention group
Group type: COMPARATOR
Intervention: No eye coverage during surgery
Number of subjects: 60
Study 33332396 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness Qigong
Number of subjects: 103
Study 33332396 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 103
Study 33332396 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 103
Study 34836822 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (educational day, clinical supervision, reminders)
Number of subjects: 258
Study 34836822 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 258
Study 34109630 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 242
Study 34109630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 32527346 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing 100 mL group
Number of subjects: 60
Study 32527346 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing 50 mL group
Number of subjects: 60
Study 32527346 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment group
Number of subjects: 60
Study 35312778 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity-based group (treatment group)
Number of subjects: 25
Study 35312778 — intervention group
Group type: COMPARATOR
Intervention: Individual-level (control group)
Number of subjects: 25
Study 34579741 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisodamine (0.1-0.5 mg/kg/hour)
Number of subjects: 355
Study 34579741 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 355
Study 35250582 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with honeysuckle before rash occurred (Arm A)
Number of subjects: 139
Study 35250582 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic treatment with honeysuckle when rash occurred (Arm B)
Number of subjects: 139
Study 35250582 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with minocycline and a topical solution when rash occurred (Arm C)
Number of subjects: 139
Study 35250582 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with honeysuckle (Arm A)
Number of subjects: 139
Study 35250582 — intervention group
Group type: EXPERIMENTAL
Intervention: Honeysuckle treatment (Arm A, B)
Number of subjects: 139
Study 34292474 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure target of 110–139 mm Hg
Number of subjects: 171
Study 34292474 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment blood pressure target of 140–179 mm Hg
Number of subjects: 171
Study 34292474 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diffusion-weighted imaging hyperintense lesions
Number of subjects: 171
Study 33896847 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral stimulation of the subthalamus nuclei (STN‐DBS)
Number of subjects: 18
Study 33896847 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral or bilateral STN‐DBS
Number of subjects: 18
Study 33896847 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 18
Study 33358203 — intervention group
Group type: EXPERIMENTAL
Intervention: Social robot intervention (PARO)
Number of subjects: 41
Study 33358203 — intervention group
Group type: COMPARATOR
Intervention: Usual care condition
Number of subjects: 41
Study 32896359 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra segmental training (CWHIt)
Number of subjects: 30
Study 32896359 — intervention group
Group type: COMPARATOR
Intervention: No training (CWHI)
Number of subjects: 30
Study 34232456 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise for 12 weeks
Number of subjects: 105
Study 34232456 — intervention group
Group type: COMPARATOR
Intervention: Health education for 12 weeks (Control)
Number of subjects: 105
Study 32149480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral anodal transcranial direct current stimulation (tDCS) applied over the left and right prefrontal and motor areas, 10 sessions (20‐min durations, five per week)
Number of subjects: 50
Study 32149480 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS stimulation
Number of subjects: 50
Study 35072694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention for New Interns (7 hour-long sessions of a monthly mindfulness curriculum)
Number of subjects: 340
Study 35072694 — intervention group
Group type: COMPARATOR
Intervention: Active control (monthly 1-hour social lunches)
Number of subjects: 340
Study 35072694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention for New Interns
Number of subjects: 340
Study 35072694 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 340
Study 33952195 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment in a single-arm design
Number of subjects: 0
Study 33952195 — intervention group
Group type: COMPARATOR
Intervention: Single-arm design
Number of subjects: 0
Study 33952195 — intervention group
Group type: COMPARATOR
Intervention: Fixed designs
Number of subjects: 0
Study 33952195 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-sequential two-arm trials
Number of subjects: 0
Study 33952195 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed single-arm design
Number of subjects: 0
Study 32840074 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music (rock music)
Number of subjects: 15
Study 32840074 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music (classical music)
Number of subjects: 15
Study 32840074 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music (any type)
Number of subjects: 15
Study 32840074 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 15
Study 32840074 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 15
Study 32840074 — intervention group
Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 15
Study 33780481 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin, diethylcarbamazine, and albendazole (IDA)
Number of subjects: 55
Study 33780481 — intervention group
Group type: COMPARATOR
Intervention: Diethylcarbamazine plus albendazole (DA)
Number of subjects: 55
Study 33780481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 55
Study 32503661 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-facilitated cancer symptom control (E2C2) intervention, which includes two levels of care: Level 1 - low-touch automated self-management support; Level 2 - nurse-managed collaborative care for severe symptoms.
Number of subjects: 0
Study 32503661 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-facilitated cancer symptom control (E2C2) intervention
Number of subjects: 0
Study 32019539 — intervention group
Group type: EXPERIMENTAL
Intervention: RFR + PFP
Number of subjects: 542
Study 32019539 — intervention group
Group type: EXPERIMENTAL
Intervention: RFR only
Number of subjects: 542
Study 32019539 — intervention group
Group type: COMPARATOR
Intervention: PFP only
Number of subjects: 542
Study 34676618 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-guided incentive spirometry for 48 hours postextubation
Number of subjects: 89
Study 34676618 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study 35300729 — intervention group
Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 18 or higher
Number of subjects: 249
Study 35300729 — intervention group
Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 22 or higher
Number of subjects: 249
Study 35300729 — intervention group
Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 20
Number of subjects: 249
Study 32753874 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 11
Study 32753874 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 11
Study 36198061 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 180 μg
Number of subjects: 380
Study 36198061 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 120 μg
Number of subjects: 380
Study 36198061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study 36029330 — intervention group
Group type: EXPERIMENTAL
Intervention: RIRS (Group A)
Number of subjects: 186
Study 36029330 — intervention group
Group type: COMPARATOR
Intervention: MiniPerc (Group B)
Number of subjects: 186
Study 36481692 — intervention group
Group type: COMPARATOR
Intervention: 3D‐conformal radiotherapy (3D‐RT)
Number of subjects: 34
Study 36481692 — intervention group
Group type: EXPERIMENTAL
Intervention: VMAT planning
Number of subjects: 34
Study 36481692 — intervention group
Group type: COMPARATOR
Intervention: 3D‐RT
Number of subjects: 34
Study 33743583 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-based estimation of Cox's model for time-dependent hazard ratio
Number of subjects: 0
Study 33743583 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-based estimation of Cox's model for log-linear hazard ratio
Number of subjects: 0
Study 33743583 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison to partial likelihood estimator and two other IV-based approaches
Number of subjects: 0
Study 36273769 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 251
Study 36273769 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 251
Study 34636355 — intervention group
Group type: EXPERIMENTAL
Intervention: Gellhorn pessary
Number of subjects: 181
Study 34636355 — intervention group
Group type: COMPARATOR
Intervention: Ring pessary
Number of subjects: 181
Study 34636355 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model
Number of subjects: 181
Study 34370925 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy interventions for daily activities and quality of life
Number of subjects: 0
Study 34370925 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33109252 — intervention group
Group type: EXPERIMENTAL
Intervention: Kabasura Kudineer (KSK) - 60ml decoction orally in the morning and evening for 14 days
Number of subjects: 60
Study 33109252 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C (60000 IU) and Zinc (100mg) - orally in the morning and evening for 14 days
Number of subjects: 60
Study 34431493 — intervention group
Group type: EXPERIMENTAL
Intervention: LLF580 300 mg subcutaneously every 4 weeks for 3 doses
Number of subjects: 64
Study 34431493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34278392 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor microorganisms (bacterial genera from Actinobacteria, Alphaproteobacteria, and Cyanobacteria)
Number of subjects: 308
Study 34278392 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor microorganisms (four fungal genera from Ascomycota: Devriesia, Endocarpon, Sarcinomyces, and an unclassified genus from Herpotrichillaceae)
Number of subjects: 308
Study 34278392 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust mite (HDM) allergens and outdoor NO2 concentration
Number of subjects: 308
Study 32584117 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioral therapy (CBT)
Number of subjects: 101
Study 32584117 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (before treatment)
Number of subjects: 101
Study 34980572 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture group (P) - shown preoperative photograph for 5 min at each postoperative visit
Number of subjects: 29
Study 34980572 — intervention group
Group type: COMPARATOR
Intervention: No picture group (NP) - not shown preoperative photograph
Number of subjects: 29
Study 34376233 — intervention group
Group type: EXPERIMENTAL
Intervention: Default strategy within the mechanical ventilation order
Number of subjects: 12
Study 34376233 — intervention group
Group type: EXPERIMENTAL
Intervention: Accountable justification strategy within the mechanical ventilation order
Number of subjects: 12
Study 34376233 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of default strategy and accountable justification strategy within flowsheet documentation
Number of subjects: 12
Study 34376233 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12
Study 34376233 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowsheet documentation strategy (adopted by all ICUs 6 months after initial strategies)
Number of subjects: 12
Study 33185167 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injections of Platelet Rich Plasma (PRP), 3 injections at monthly intervals.
Number of subjects: 60
Study 33185167 — intervention group
Group type: COMPARATOR
Intervention: Single intra-articular injection of steroid.
Number of subjects: 60
Study 33183362 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 62
Study 33183362 — intervention group
Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (EST)
Number of subjects: 62
Study 33199051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55
Study 33199051 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study 32925045 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, vascular risk management)
Number of subjects: 60
Study 32925045 — intervention group
Group type: COMPARATOR
Intervention: General health advice (control group)
Number of subjects: 60
Study 37207014 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPERA technique
Number of subjects: 36
Study 37207014 — intervention group
Group type: COMPARATOR
Intervention: Hybrid technique
Number of subjects: 36
Study 36376127 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Number of subjects: 150
Study 36376127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy (Cold Vibration Device)
Number of subjects: 150
Study 36376127 — intervention group
Group type: COMPARATOR
Intervention: Control Group (Distraction technique of talking and asking questions)
Number of subjects: 150
Study 34002035 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 898130
Study 34002035 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted WHR
Number of subjects: 898130
Study 33302667 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversified and staged health education
Number of subjects: 180
Study 33302667 — intervention group
Group type: COMPARATOR
Intervention: Routine health education
Number of subjects: 180
Study 34698501 — intervention group
Group type: EXPERIMENTAL
Intervention: GRAd-COV2 vaccine (single intramuscular administration at three escalating doses)
Number of subjects: 90
Study 34698501 — intervention group
Group type: EXPERIMENTAL
Intervention: GRAd-COV2 vaccine
Number of subjects: 90
Study 34943312 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose, high-frequency simulation training
Number of subjects: 0
Study 34943312 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 0
Study 34943312 — intervention group
Group type: EXPERIMENTAL
Intervention: At least monthly training
Number of subjects: 0
Study 34933644 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ with 6g β-glucan
Number of subjects: 0
Study 34933644 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ with 3g β-glucan
Number of subjects: 0
Study 34933644 — intervention group
Group type: COMPARATOR
Intervention: OJ alone
Number of subjects: 0
Study 32065984 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT), n = 17
Number of subjects: 38
Study 32065984 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational group (OCD-EP), n = 21
Number of subjects: 38
Study 34982820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) therapy
Number of subjects: 13487
Study 34982820 — intervention group
Group type: COMPARATOR
Intervention: Usual care (comparison group)
Number of subjects: 13487
Study 33938952 — intervention group
Group type: EXPERIMENTAL
Intervention: Klar bleiben intervention (contract management, feedback system)
Number of subjects: 92
Study 33938952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study 34001823 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analysis of PET/CT
Number of subjects: 30
Study 34001823 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest classifier on training set
Number of subjects: 30
Study 34001823 — intervention group
Group type: EXPERIMENTAL
Intervention: Model on independent test set
Number of subjects: 30
Study 32271833 — intervention group
Group type: EXPERIMENTAL
Intervention: READY for MS (resilience group training program based on Acceptance and Commitment Therapy)
Number of subjects: 39
Study 32271833 — intervention group
Group type: COMPARATOR
Intervention: Relaxation (active control intervention)
Number of subjects: 39
Study 32271833 — intervention group
Group type: EXPERIMENTAL
Intervention: READY for MS
Number of subjects: 39
Study 32271833 — intervention group
Group type: COMPARATOR
Intervention: Relaxation + READY (after trial completion)
Number of subjects: 39
Study 35342289 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium bromide/formoterol fumarate (AB/FF)
Number of subjects: 250
Study 35342289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 32040398 — intervention group
Group type: EXPERIMENTAL
Intervention: New Nutrition Facts label (NFL)
Number of subjects: 1156
Study 32040398 — intervention group
Group type: COMPARATOR
Intervention: Current Nutrition Facts label (NFL)
Number of subjects: 1156
Study 34172640 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line hemodiafiltration (OL-HDF)
Number of subjects: 47
Study 34172640 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (CHD)
Number of subjects: 47
Study 34108229 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 1471
Study 34108229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1471
Study 35312347 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis
Number of subjects: 112
Study 35312347 — intervention group
Group type: COMPARATOR
Intervention: Digital Mammography
Number of subjects: 112
Study 32426812 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin distributions
Number of subjects: 0
Study 36191329 — intervention group
Group type: EXPERIMENTAL
Intervention: Permitting suggestions: 'You are aware of your surroundings and any distractions that might disturb your dream.'
Number of subjects: 32
Study 36191329 — intervention group
Group type: EXPERIMENTAL
Intervention: Excluding suggestions: 'No outside stimulus will disturb your sleep.'
Number of subjects: 32
Study 34142500 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot assisted percutaneous reduction and cannulated screw fixation through tarsal sinus incision
Number of subjects: 44
Study 34142500 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation via traditional tarsal sinus incision
Number of subjects: 44
Study 34142500 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (trial and control)
Number of subjects: 44
Study 35311975 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration (ICON, DMG, Hamburg, Germany)
Number of subjects: 60
Study 35311975 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP, Toothmousse, GC corporation, Germany)
Number of subjects: 60
Study 34843141 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised milk-based formulation (SMBF)
Number of subjects: 157
Study 34843141 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised non-milk based formulation (SNMBF)
Number of subjects: 157
Study 34843141 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based formulation (HBF)
Number of subjects: 157